FDA Drug Recalls

Recalls / Class III

Class IIID-0550-2018

Product

Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co. Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01

Brand name
Cystaran
Generic name
Cysteamine Hydrochloride
Active ingredient
Cysteamine Hydrochloride
Route
Ophthalmic
NDCs
54482-020, 54482-035
FDA application
NDA200740
Affected lot / code info
Lot #: 356075, Exp 2/28/18

Why it was recalled

Subpotent Drug: Out of specification for an active ingredient cysteamine hydrochloride.

Recalling firm

Firm
LEADIANT BIOSCIENCES, INC
Manufacturer
Leadiant Biosciences, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
9841 Washingtonian Blvd Ste 500, N/A, Gaithersburg, Maryland 20878-7352

Distribution

Quantity
1,705 bottles
Distribution pattern
Product was distributed to one specialty pharmacy distributor in the US Walgreens Specialty Pharmacy 16287, 130 Enterprise Drive Pittsburgh, PA 15275 Foreign Account: Italy

Timeline

Recall initiated
2018-02-14
FDA classified
2018-02-28
Posted by FDA
2018-03-07
Terminated
2018-11-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0550-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Cystaran · FDA Drug Recalls